Abstract Library

#3843 VIPoma presenting as chronic diarrhea in a 30-year-old Filipino female

Introduction: Pancreatic neuroendocrine tumors are rare neoplasms that arise in the endocrine tissues of the pancreas. They can secrete a variety of peptide hormones including insulin, gastrin, glucagon, and vasoactive intestinal peptide. Secretory tumors such as vasoactive intestinal polypeptides are rare neuroendocrine pancreatic neoplasms characterized by watery diarrhea, hypokalemia, and hypochlorhydria.

Conference:

Presenting Author: Edejer P

Authors: Edejer P, Mendoza R, Pascasio C, Lin T, Cornelio G,

Keywords: Pancreatic NET, Octreotide, DOTATATE, diarrhea,

#3297 Update on the role of the robotic assisted surgery in the treatment of pancreatic neuroendocrine tumors in the context of MEN1

Introduction: Pancreatic surgery is technically demanding and robotic assisted surgery providing improved dexterity enables the adoption of minimally invasive pancreatic surgery. Pancreatic neuroendocrine tumors (pNETs) are rare with an incidence of one per 100,000 population, accounting for 1%-4% of all pancreatic tumors. Minimally invasive surgery has an established role in the treatment of patients with pNETs. PNETs are the second most common manifestation in patients with MEN1. The most common type of pNETs in MEN1 is a non-functional tumor.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Yiannakopoulou E,

Keywords: robotic assisted surgery, pNETs, MEN1,

#2263 Patient Survey Devoted to Characterizing Experience and Expectations of Patients with Neuroendocrine Tumors (NET)

Introduction: Patients (pts) with NET experience consequences of disease progression and treatments; their preferences can influence the choice and success of therapeutic strategies.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: SARABI M

Authors: Sarabi M, Gueguen D, Walter T, Hentic O, Baudin E,

Keywords: Patient Report Outcomes, Neuroendocrine Tumor, Quality of life,

#1844 Selective Approach in Surgical Treatment of Pancreatic Neuroendocrine Tumors

Introduction: Surgical resection is the main method in treating of pancreatic neuroendocrine tumors (pNETs) . Contemporary perioperative diagnostic can help using selective approaches, to perform organ-preserving (OP) procedures including operations with miniinvasive techniques (MI) such as robot – assisted (RA) or laparoscopic (La).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Kaldarov A

Authors: Kaldarov A, Kriger A, Berelavichus S, Gorin D, Smirnov A,

Keywords: pancreatic neuroendocrine tumors, surgical treatment, robot, assisted, miniinvasive, laparoscopic,

#1214 Initial Experience with Robot-Assisted Distal Pancreatectomy for Pancreatic Neuroendocrine Neoplasms

Introduction: Robot-assisted distal pancreatectomy (RADP) for pancreatic neuroendocrine neoplasms (pNEN) has not been investigated so far

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Partelli S

Authors: Partelli S, Cirocchi R, Crippa S, Desiderio J, Belfiori G,

Keywords: robot-assisted pancreatectomy, pancreatic neuroendocrine neoplasm, surgery,